Polyethylene Glycol and Propylene Glycol
2 NDCs across 2 manufacturers|1 Generic,1 Brand
▸ More about this market▾ Less
Polyethylene Glycol and Propylene Glycol is available as 2 NDCs from 2 manufacturers (1 generic, 1 brand), with NADAC prices from $0.65 to $0.65 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
1G / 1B
Manufacturers
2
competing in market
Price Spread
$0.65 – $0.65
per ML, 1 of 2 NDCs
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Cardinal Health manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DRY EYE RELIEF 0.3-0.4% DROP | $0.6476 per ML | — |
SYSTANE 0.3-0.4% EYE DROP | $0.3756 per EA | — |
Frequently Asked Questions
How many Polyethylene Glycol and Propylene Glycol products are on the market?
The Polyethylene Glycol and Propylene Glycol drug market contains 2 NDCs from 2 manufacturers — 1 generic and 1 brand product.
What is the price range for Polyethylene Glycol and Propylene Glycol?
NADAC reference prices for Polyethylene Glycol and Propylene Glycol range from $0.6476 to $0.6476 per ML. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Polyethylene Glycol and Propylene Glycol?
2 manufacturers list Polyethylene Glycol and Propylene Glycol in NADAC. Ranked by number of NDCs, the largest are Cardinal Health (1), Alcon Research Ltd (1).